D. Izard

3.0k total citations
103 papers, 2.3k citations indexed

About

D. Izard is a scholar working on Molecular Biology, Endocrinology and Molecular Medicine. According to data from OpenAlex, D. Izard has authored 103 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 34 papers in Endocrinology and 31 papers in Molecular Medicine. Recurrent topics in D. Izard's work include Antibiotic Resistance in Bacteria (31 papers), Genomics and Phylogenetic Studies (30 papers) and Enterobacteriaceae and Cronobacter Research (27 papers). D. Izard is often cited by papers focused on Antibiotic Resistance in Bacteria (31 papers), Genomics and Phylogenetic Studies (30 papers) and Enterobacteriaceae and Cronobacter Research (27 papers). D. Izard collaborates with scholars based in France, Lebanon and Belgium. D. Izard's co-authors include H Leclerc, F. Gavini, K. Kersters, J. De Ley, N. Baida, M. Elomari, Joris Mergaert, Fouad Dabboussi, Christine Mielcarek and Monzer Hamzé and has published in prestigious journals such as Applied and Environmental Microbiology, Analytical Biochemistry and Social Science & Medicine.

In The Last Decade

D. Izard

91 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Izard France 28 988 744 432 430 335 103 2.3k
Vilma A. Stanisich Australia 18 1.2k 1.2× 746 1.0× 210 0.5× 633 1.5× 419 1.3× 36 2.5k
F. Gavini France 28 1.1k 1.1× 465 0.6× 469 1.1× 243 0.6× 260 0.8× 80 2.4k
Sophie Mangenot France 24 1.3k 1.3× 741 1.0× 462 1.1× 414 1.0× 749 2.2× 31 2.7k
S. P. Lapage Nepal 24 1000 1.0× 397 0.5× 615 1.4× 374 0.9× 207 0.6× 58 2.3k
Yoshimasa Kosako Japan 24 1.2k 1.2× 1.2k 1.6× 489 1.1× 719 1.7× 157 0.5× 43 3.0k
D.G. Pitcher United Kingdom 17 1.1k 1.1× 432 0.6× 475 1.1× 496 1.2× 159 0.5× 24 2.7k
S E West United States 25 2.4k 2.4× 381 0.5× 526 1.2× 453 1.1× 655 2.0× 35 3.8k
Massimo Merighi United States 21 1.0k 1.0× 436 0.6× 391 0.9× 201 0.5× 334 1.0× 30 1.9k
Martin J. Day United Kingdom 30 955 1.0× 648 0.9× 344 0.8× 1.1k 2.6× 340 1.0× 76 2.8k
H.J.M. Aarts Netherlands 28 1.4k 1.5× 399 0.5× 380 0.9× 482 1.1× 458 1.4× 58 3.0k

Countries citing papers authored by D. Izard

Since Specialization
Citations

This map shows the geographic impact of D. Izard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Izard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Izard more than expected).

Fields of papers citing papers by D. Izard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Izard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Izard. The network helps show where D. Izard may publish in the future.

Co-authorship network of co-authors of D. Izard

This figure shows the co-authorship network connecting the top 25 collaborators of D. Izard. A scholar is included among the top collaborators of D. Izard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Izard. D. Izard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romond, Marie‐Bénédicte, et al.. (2008). Intestinal colonization with bifidobacteria affects the expression of galectins in extraintestinal organs. FEMS Immunology & Medical Microbiology. 55(1). 85–92. 6 indexed citations
2.
Romond, Marie‐Bénédicte, Catherine Mullié, Nicolas Kalach, et al.. (2007). Does the intestinal bifidobacterial colonisation affect bacterial translocation?. Anaerobe. 14(1). 43–48. 32 indexed citations
3.
Loïez, Caroline, et al.. (2006). [Spondylodiscitis due to Salmonella enteritica serotype Typhi].. PubMed. 63(5). 517–8. 2 indexed citations
4.
Loïez, Caroline, N. Baida, Fouad Dabboussi, et al.. (2004). Épidémiologie des infections provoquées par les bactéries du « complexe Burkholderia cepacia » au cours de la mucoviscidose. Archives de Pédiatrie. 11(4). 360–366. 2 indexed citations
5.
Hamzé, Monzer, Fouad Dabboussi, & D. Izard. (2003). Sensibilité des entérobactéries aux antibiotiques : étude sur quatre ans (1998-2001) dans le nord du Liban. Cahiers d'études et de recherches francophones / Santé. 13(2). 107–112. 2 indexed citations
6.
Odou, Marie‐Françoise, et al.. (2003). Multiplex PCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. FEMS Microbiology Letters. 222(1). 129–136. 51 indexed citations
8.
Meyer, Jean‐Marie, Valérie Geoffroy, N. Baida, et al.. (2002). Siderophore Typing, a Powerful Tool for the Identification of Fluorescent and Nonfluorescent Pseudomonads. Applied and Environmental Microbiology. 68(6). 2745–2753. 138 indexed citations
9.
Baida, N., et al.. (2002). Pseudomonas grimontii sp. nov.. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 52(5). 1497–1503. 27 indexed citations
10.
Dabboussi, Fouad, Monzer Hamzé, M. Elomari, et al.. (1999). Taxonomic study of bacteria isolated from Lebanese spring waters: proposal for sp. nov. and sp. nov.. Research in Microbiology. 150(5). 303–316. 37 indexed citations
11.
Elomari, M., et al.. (1997). Phenotypically Based Taxonomy of Fluorescent Pseudomonas Strains Isolated from Four Natural Mineral Waters. Systematic and Applied Microbiology. 20(1). 137–149. 5 indexed citations
12.
Mégraud, Françis, et al.. (1988). GC content of DNA of Campylobacter pylori and other species belonging or related to the genus Campylobacter. Annales de l Institut Pasteur Microbiologie. 139(5). 527–534. 16 indexed citations
13.
Izard, D., et al.. (1986). In vitro activity of pefloxacin.. PubMed. 12(4). 313–7. 5 indexed citations
14.
Freney, J., F. Gavini, Hervé Alexandre, et al.. (1986). Nosocomial infection and colonization by Klebsiella trevisanii. Journal of Clinical Microbiology. 23(5). 948–950. 39 indexed citations
15.
Izard, D., et al.. (1984). Evaluation of the four-hour rapid 20E system for identification of members of the family Enterobacteriaceae. Journal of Clinical Microbiology. 20(1). 51–54. 20 indexed citations
16.
Husson, M., René Courcol, D. Izard, & H Leclerc. (1984). Ceftizoxime (FK 749) in vitro antibacterial activity. Infection. 12(1). 40–45. 1 indexed citations
17.
Izard, D., et al.. (1983). [Immunological study of glyceraldehyde-3-phosphate dehydrogenase in Enterobacteriaceae; taxonomic value].. PubMed. 134A(2). 127–39. 1 indexed citations
18.
Trinel, P.A., et al.. (1983). Étude immunologique de la glycéraldéhyde-3-phosphate-déshydrogénase chez les entérobactéries; intérêt taxonomique. Annales de l Institut Pasteur Microbiologie. 134(2). 127–139. 3 indexed citations
19.
Izard, D., et al.. (1983). [Rapid, automatic methods for identifying enterobacteria].. PubMed. 41(6). 419–26. 1 indexed citations
20.
Izard, D., Annie Husson, Claude Richard, F. Gavini, & H Leclerc. (1982). Study of the species Enterobacter gergoviae by DNA/DNA hybridization.. 371–376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026